about
PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1Concerted action of Nrf2-ARE pathway, MRN complex, HMGB1 and inflammatory cytokines - implication in modification of radiation damageOncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial CellsMass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseaseChlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cellsNovel HMGB1-inhibiting therapeutic agents for experimental sepsis.High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.RAGE expression in human T cells: a link between environmental factors and adaptive immune responses.Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitationHMGB1 in health and disease.Mast cell stabilization improves survival by preventing apoptosis in sepsisUnphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis.Store-operated Ca2+ entry plays a role in HMGB1-induced vascular endothelial cell hyperpermeability.Potential role of high mobility group box 1 in viral infectious diseasesHigher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.Proteogenomics of synaptosomal mitochondrial oxidative stress.Methylprednisolone Protects Cardiac Pumping Mechanics from Deteriorating in Lipopolysaccharide-Treated Rats.Therapeutic potential of HMGB1-targeting agents in sepsis.Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model.Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions.TLR4-Activated MAPK-IL-6 Axis Regulates Vascular Smooth Muscle Cell Function.Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.Amino acid residues 201-205 in C-terminal acidic tail region plays a crucial role in antibacterial activity of HMGB1.Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.New Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.Novel insights for systemic inflammation in sepsis and hemorrhage.High-mobility group box 1, oxidative stress, and disease.Innate immune signaling in cardiac ischemia.High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation.MEMBRANE TYPE 1-MATRIX METALLOPROTEINASE (MT1-MMP) IDENTIFIED AS A MULTIFUNCTIONAL REGULATOR OF VASCULAR RESPONSES.TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway.Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes.Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.Fatty acids do not pay the toll: effect of SFA and PUFA on human adipose tissue and mature adipocytes inflammationInflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways.Inhibition of mTOR reduces lipotoxic cell death in primary macrophages through an autophagy-independent mechanismHMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion.Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1.
P2860
Q26738811-9C37D854-059C-4185-848F-717539226575Q26995211-C7706835-F86F-412E-A98E-8276C13FFC2EQ27488206-74F3AFFF-5E97-4445-81CE-150EBF892C67Q28075372-60DDB0F9-2BC3-48C4-9518-8A84C460D90AQ33320332-894882E3-4845-45B2-9BDE-9733DA76AD1AQ33814903-355EC270-2666-4C4F-BED0-427B85ED6069Q33836853-6A824F4E-D42B-4D50-AF48-16759CB7BE56Q34235391-39B7C891-E1BD-4F8C-905A-D071388AFB7EQ34336825-6568E686-8403-44C9-BA5A-40739F9B5F99Q34615609-8CDFD338-0423-4D10-8CD3-56F896815F8EQ34622835-A34FF87F-8E29-42D4-BE8C-8162D767754CQ34872619-CFE4CE41-BCC5-4A77-8842-388BD52ECAEEQ34905862-179A3361-5DD0-4AE0-9299-C5003F5FBDD7Q35462467-9B3823E4-010A-452A-8B73-4AB18B9A4647Q35610215-A509C68B-C954-4460-9D26-6A1BC93E7C35Q36138225-6A073991-D60C-4F10-9BC8-FBA75F166642Q36215789-3C20F333-CBFC-4574-9AA3-1BBF059E0AABQ36320106-12005503-1B32-428D-A736-694A570BB610Q36981872-10ECA207-1D3C-4FDE-A29B-EFF76996FE89Q37003895-D029AC2C-995F-4F27-8AB0-5421649902F6Q37216851-0D6276FB-C15D-4480-97AC-D78AA7E7AC26Q37286256-9B99CEDD-128B-41DC-9B9D-F9219BDEB493Q37349924-E9BE77BF-278E-4649-9EA2-575226CBF757Q37368548-91EB490B-3F52-4644-B0BB-FBC4EBE956E7Q37438177-D83F3F09-541C-4842-8D9B-34D55348FCAAQ37590946-C8C79EDC-38DC-43AF-9227-693D91981C4EQ37729101-3C4BF6C7-3B1B-4DE3-ADD5-B4BFB4599D51Q37772404-30EDE8E3-197C-440E-A770-D6CC63961C42Q37802381-67C45398-9494-439D-A12B-AC9829B387B7Q37859249-85B37FBA-D2E7-487E-9764-4065098F6ABEQ38334036-B54ED994-3A5F-4AAA-B178-1ECD69F3C3FBQ38586884-5DDF3AC9-A9E1-4995-A020-96144D23D546Q39218682-8D9DCEAE-7BF8-4ECF-AA8A-70C9237E8236Q39369013-2B1E4861-A061-44FB-881C-DD08D762993EQ41317574-419565EA-AAE6-45C5-BFEC-96C92281BADAQ41852380-B650B3E4-FF1A-4126-985F-AEA37F6BD621Q42611487-29F5A5F0-7D1B-4528-818C-06796C4E8B24Q42707223-7B4880C5-86E0-49F8-A9CC-CA0305F06058Q43844401-6C24BB33-BA1F-4DDC-AAB4-F5D7B310A442Q45158260-C4572CDB-2563-4BE2-9446-1BF7BB1BBAB9
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of HMGB1 in cardiovascular diseases
@ast
Role of HMGB1 in cardiovascular diseases
@en
type
label
Role of HMGB1 in cardiovascular diseases
@ast
Role of HMGB1 in cardiovascular diseases
@en
prefLabel
Role of HMGB1 in cardiovascular diseases
@ast
Role of HMGB1 in cardiovascular diseases
@en
P2860
P1476
Role of HMGB1 in cardiovascular diseases
@en
P2093
P2860
P304
P356
10.1016/J.COPH.2005.10.010
P50
P577
2006-02-17T00:00:00Z